Skip to content

GENVOR INCORPORATED: 10-Q filed 2025-06-30

What GENVOR INCORPORATED reported in its quarterly report filed 2025-06-30 (fiscal Q3 2024): 29 published measures, 89 facts as tagged in accession 0001903596-25-000325.

This filing

Form
10-Q (quarterly report)
Filed
2025-06-30
Fiscal period
fiscal Q3 2024
Accession
0001903596-25-000325 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENVOR INCORPORATED filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-3023,554USD
At 2023-09-3082,063USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-301,591,418USD
At 2023-09-301,787,059USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-06-30-1,567,864USD
At 2024-03-31-1,101,047USD
At 2023-12-31-1,193,242USD
At 2023-09-30-1,704,996USD
At 2023-06-30-1,760,304USD
At 2023-03-31-1,632,775USD
At 2022-12-31-1,424,063USD
At 2022-09-30-1,394,444USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-601,877USD91
2023-10-01 to 2024-06-30-2,725,359USD274
2024-01-01 to 2024-03-31-772,055USD91
2023-10-01 to 2023-12-31-1,351,427USD92
2023-04-01 to 2023-06-30-215,029USD91
2022-10-01 to 2023-06-30-615,860USD273
2023-01-01 to 2023-03-31-221,212USD90
2022-10-01 to 2022-12-31-179,619USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-10-01 to 2024-06-30-955,873USD274
2022-10-01 to 2023-06-30-583,786USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-10-01 to 2024-06-30911,660USD274
2022-10-01 to 2023-06-30287,500USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-20,444,666USD
At 2023-09-30-17,719,307USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-3020,222,081shares91
2023-10-01 to 2024-06-3019,758,953shares274
2023-04-01 to 2023-06-3018,502,546shares91
2022-10-01 to 2023-06-3019,800,317shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-3020,222,081shares91
2023-10-01 to 2024-06-3019,758,953shares274
2023-04-01 to 2023-06-3018,502,546shares91
2022-10-01 to 2023-06-3019,800,317shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.03USD/shares91
2023-10-01 to 2024-06-30-0.14USD/shares274
2023-04-01 to 2023-06-30-0.01USD/shares91
2022-10-01 to 2023-06-30-0.03USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.03USD/shares91
2023-10-01 to 2024-06-30-0.14USD/shares274
2023-04-01 to 2023-06-30-0.01USD/shares91
2022-10-01 to 2023-06-30-0.03USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-06-3014,359USD
At 2023-09-3015,734USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-10-01 to 2024-06-301,363,350USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-571,833USD91
2023-10-01 to 2024-06-30-2,624,309USD274
2023-04-01 to 2023-06-30-149,072USD91
2022-10-01 to 2023-06-30-418,015USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-309,195USD
At 2023-09-3066,329USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-10-01 to 2024-06-3016,832USD274
2023-04-01 to 2023-06-305,846USD91
2022-10-01 to 2023-06-3017,511USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-301,591,418USD
At 2023-09-301,787,059USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-30571,833USD91
2023-10-01 to 2024-06-302,624,309USD274
2023-04-01 to 2023-06-30149,072USD91
2022-10-01 to 2023-06-30418,015USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-04-01 to 2024-06-3043,801USD91
2023-10-01 to 2024-06-30206,911USD274
2023-04-01 to 2023-06-300USD91
2022-10-01 to 2023-06-300USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3020,239,608shares
At 2023-09-3019,061,936shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-06-30141USD
At 2023-09-3044,354USD
At 2023-06-30100USD
At 2022-09-30296,386USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-3019,154,501USD
At 2023-09-3016,293,188USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-06-3058,630USD
At 2023-09-30302,025USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-601,877USD91
2023-10-01 to 2024-06-30-2,725,359USD274
2023-04-01 to 2023-06-30-215,029USD91
2022-10-01 to 2023-06-30-615,860USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-10-01 to 2024-06-30-2,725,000USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-10-01 to 2024-06-301,375USD274
2022-10-01 to 2023-06-301,374USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-44USD91
2023-10-01 to 2024-06-305,782USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-30,044USD91
2023-10-01 to 2024-06-30-101,050USD274
2023-04-01 to 2023-06-30-65,957USD91
2022-10-01 to 2023-06-30-197,845USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-10-01 to 2024-06-30911,600USD274
2022-10-01 to 2023-06-30237,500USD273

Inspect the source

Entity
GENVOR INCORPORATED / CIK 0001792941
Captured
2026-09-21T17:27:40.419Z
SEC response SHA-256
3dda2e031208b06de0ad4f526a7b0b69c20a62c66e0a58841d63f8c48f29fe20

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001792941.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))